People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

The US Food and Drug Administration (FDA) on Monday urged patients and healthcare providers to verify the authenticity of their Ozempic ...

Canada's new obesity guidelines signal a shift in food consumption, with GLP-1 drugs impacting how and what Canadians—especially youth—eat.

Mounjaro's launch of a weight-loss drug has sparked interest amongst the people of India despite the high price. Experts believe that making the drug locally available would help to reduce the black ...

I’m Kelly Grant, a health reporter with The Globe and Mail. Yesterday, the Canadian Medical Association Journal published the first new guideline on the treatment of childhood obesity in nearly 20 ...

The maker of Ozempic and the weight loss drug Wegovy told the FDA on April 3 that counterfeit 1-milligram injections were ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.

The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

During a recent finance committee meeting, Deputy Comptroller Delano Dowell confirmed to the Common Council that so far in fiscal year 2024-2025, Buffalo has incumbered $2.1 million of unexpected ...

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

The drugmaker said it would stop studying danuglipron after a participant had a possible drug-induced liver injury.